Tmunity Therapeutics Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Total Funding:$150M
Industry:Biotech
Founded:2015
Lead Investor(s):Kleiner Perkins
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Tmunity Therapeutics's estimated annual revenue is currently $10.2M per year.
  • Tmunity Therapeutics received $35.0M in venture funding in April 2018.
  • Tmunity Therapeutics's estimated revenue per employee is $155,000
  • Tmunity Therapeutics's total funding is $150M.

Employee Data

  • Tmunity Therapeutics has 66 Employees.
  • Tmunity Therapeutics grew their employee count by 29% last year.
  • Tmunity Therapeutics currently has 1 job openings.

Executive Contacts

NameTitleEmail
Usman AzamPresident & CEOEmail Available
Zoe ZhengSenior Director, Process Development
Michael TownsleyExecutive Director, Quality Assurance
Kimberly SmithVP of Finance and
Lori GavrinExecutive Director Of Business Development
Karen ChaginVp, Clinical Development Program Lead
Michelle ChessSenior Manager, Accounting
Jason KrentzChief Technology Officer - Head of Technical OperationsEmail Available
David GeogheganVice President, Head Of Quality
Elizabeth ShreveQuality Manager

Our vision is to become the leading innovative global life-sciences company that unlocks the potential of T-cell biology and combines it with the power of T-cell engineering excellence to provide cures for patients. Through our model of seamless and rapid integration of research, translational medicine, manufacturing science, clinical development and customer-centric approaches, we will design and deliver enhanced state-of-the-art solutions for patients in a host of disease areas using Chimeric Antigen Receptors (CARs), Gene edited T-Cells, T regulatory cells (Treg), and engineered T Cell Receptors (TCRs)

keywords:N/A

66

Number of Employees

$10.2M

Revenue (est)

1

Current Jobs

29%

Employee Growth %

$150M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Rockland Immuno...
$14.1M9112%N/A
Braeburn
$9.6M62-29%N/A
Allevi
N/A23N/AN/A
Passage Bio
$5M32N/AN/A
DrugScan
$22.3M144-5%N/A
TechData Servic...
$11.2M72-1%N/A
Spark Therapeut...
$69.1M44620%N/A
Caliber Infosol...
N/A13N/AN/A
BioTelemetry
$377.3M9762%N/A
Strongbridge Bi...
$13.5M87-24%N/A
Missing a competitor? Contribute!?
Submit

Tmunity Therapeutics News

08/23/2019 - Tmunity Announces Participation at Upcoming Investor ...

PHILADELPHIA--(BUSINESS WIRE)--Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and ...

08/27/2019 - Alliance Task Force Joins Consensus against Germline Gene ...

“As therapeutic developers utilizing gene-editing technologies, we must ... Therapeutics, Precision Biosciences, and Tmunity Therapeutics.

01/09/2019 - With new data, new targets, Tmunity Therapeutics to gather ...

SAN FRANCISCO—Nearly a year after Tmunity Therapeutics raised $100 million to develop better and safer T cell treatments, the company is ...

Tmunity Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-01-24$100.0MAMultipleArticle
2018-04-20$35.0MAKleiner PerkinsArticle

Tmunity Therapeutics Executive Hires

DateNameTitleReference
2017-05-10Michael ChristianoEVP and Chief Business OfficerArticle
2018-04-04Jason KrentzCTO & Head of Technical OperationsArticle
2018-07-11Christina CoughlinChief Medical Officer/evpArticle
2018-09-05Graeme BellEVP//CFOArticle
2018-09-19Moji JamesGeneral Counsel & EVPArticle